EDX · EP 13 · ELECTRODIAGNOSTICS
Before You Listen
Before You Listen
- Prerequisites: the basic motor unit (alpha motor neuron, axon, neuromuscular junctions, all innervated muscle fibers); compound muscle action potential (CMAP) recording with surface electrodes after supramaximal nerve stimulation; sensory nerve action potential (SNAP) recording; the difference between presynaptic and postsynaptic locations at a chemical synapse; standard needle EMG terminology (insertional activity, motor unit action potentials, recruitment).
- Runtime: approximately 1 hour 12 minutes.
- Topic in one line: the physiology of normal neuromuscular junction (NMJ) transmission (quantal content m, quantal response q, safety factor 3 to 5x (Wood & Slater 2001 Prog Neurobiol canonical), readily releasable pool depletion); slow-rate repetitive nerve stimulation (RNS) at 2 to 3 hertz with decremental response and U-shaped recovery, post-activation facilitation, and post-activation exhaustion; the high-rate RNS or 10-second post-exercise increment >100% as the hallmark of presynaptic disease; single-fiber EMG (SFEMG) jitter and blocking as the most sensitive test; myasthenia gravis (MG) as the postsynaptic prototype (anti-AChR 80-90%, anti-MuSK 5-10%, thymoma 10-15%, normal baseline CMAP with decrement); Lambert-Eaton myasthenic syndrome (LEMS) as the presynaptic prototype (anti-P/Q-type VGCC, ~60% paraneoplastic with small cell lung cancer, low baseline CMAP with dramatic >100% increment); botulism (SNARE cleavage, 30-100% increment); congenital myasthenic syndromes (slow-channel and COLQ worsened by pyridostigmine); immune checkpoint inhibitor-associated MG; and “low CMAP = presynaptic” as the rule that solves most NMJ board questions.
Vignette. A 63-year-old man with a 40-pack-year smoking history presents with progressive proximal lower extremity weakness over 3 months, dry mouth, constipation, and erectile dysfunction. His tendon reflexes are diminished at rest. After he performs 10 seconds of vigorous voluntary contraction of his hand, the previously absent ankle reflex returns transiently. Motor nerve conduction studies of the abductor digiti minimi show a baseline compound muscle action potential (CMAP) amplitude of 1.8 millivolts (laboratory normal greater than 5). After 10 seconds of maximum voluntary abduction of the fifth digit, the CMAP amplitude rises to 5.6 millivolts. Sensory nerve action potentials are normal. Slow-rate repetitive nerve stimulation at 3 hertz of the same nerve shows a 22% decrement.
What is the diagnosis, what specific antibody confirms the pathophysiology, what is the percentage post-exercise increment in this patient (and what threshold defines a presynaptic disorder), what cancer must be aggressively screened for, and what is the first-line symptomatic treatment?
(Answer at the end of this chapter)
Section 1: Neuromuscular Junction Physiology, Safety Factor, and Vesicle Pools
Bottom line: an action potential opens P/Q-type voltage-gated calcium channels at the presynaptic terminal, calcium triggers SNARE-mediated vesicle fusion, acetylcholine (ACh) binds nicotinic ACh receptors (AChR) on the muscle fiber, and the endplate potential (EPP) is normally 3 to 5 times larger than threshold (the safety factor); presynaptic disorders reduce quantal content (m, vesicles released per impulse), postsynaptic disorders reduce quantal response (q, EPP per quantum), and when the safety factor falls below 1.0 the muscle fiber action potential fails (blocking).
The neuromuscular junction (NMJ) is the chemical synapse between the motor nerve terminal and the muscle fiber. When an action potential reaches the presynaptic terminal, it opens P/Q-type voltage-gated calcium channels (VGCCs) — the targets of Lambert-Eaton myasthenic syndrome (LEMS) autoantibodies. Calcium influx triggers fusion of acetylcholine (ACh)-containing vesicles with the presynaptic membrane through SNARE proteins (synaptobrevin/VAMP, SNAP-25, syntaxin), the proteins cleaved by botulinum toxin. ACh is released as quanta (each vesicle = one quantum, approximately 5,000 to 10,000 ACh molecules) and binds nicotinic ACh receptors (AChR) on the postsynaptic membrane (the myasthenia gravis [MG] target). AChR opens to allow sodium influx, generating an endplate potential (EPP). If the EPP exceeds threshold, a muscle fiber action potential follows. Acetylcholinesterase in the cleft hydrolyzes ACh and terminates transmission.
Two physiologic quantities define the system. Quantal content (m) is the number of quanta released per impulse (normally 50 to 300). Quantal response (q) is the EPP per quantum (the miniature endplate potential, MEPP, normally 0.5 to 1.0 millivolts). Total EPP = m × q (about 50 to 70 millivolts). Threshold is approximately negative 50 to negative 55 millivolts. The safety factor is EPP/threshold, normally 3 to 5 times (Wood & Slater 2001 Prog Neurobiol). Presynaptic disorders (LEMS, botulism) reduce m. Postsynaptic disorders (MG) reduce q. When the safety factor falls below 1.0, the muscle fiber action potential fails: blocking.
The presynaptic terminal maintains three vesicle pools. The readily releasable pool (RRP) (~1,000 vesicles docked at active zones) is depleted first during repetitive stimulation. The recycling pool replenishes the RRP. The reserve pool is mobilized during prolonged activity. During slow-rate RNS at 2 to 3 hertz, replenishment cannot keep pace, and by the fourth or fifth stimulus the RRP reaches its nadir. In a healthy NMJ, this physiological decline produces no failure (safety factor adequate). In a diseased NMJ, the further decline pushes additional junctions below threshold and produces the measurable decrement.
High Yield — NMJ physiology
- P/Q-type VGCCs = LEMS antibody target; open at presynaptic terminal upon action potential arrival.
- SNARE proteins (synaptobrevin/VAMP, SNAP-25, syntaxin) = botulism toxin target; mediate vesicle fusion.
- Nicotinic AChR = MG antibody target; postsynaptic ligand-gated ion channel.
- Quantal content (m) = vesicles per impulse (50 to 300); reduced in presynaptic disease.
- Quantal response (q) = EPP per quantum (MEPP, 0.5 to 1.0 mV); reduced in postsynaptic disease.
- EPP = m × q; normally 50 to 70 mV; threshold ~ -50 to -55 mV.
- Safety factor = EPP / threshold = 3 to 5x normal (Wood & Slater 2001). Below 1.0 = blocking (transmission failure at that junction).
- RRP (~1,000 vesicles) depletes by the 4th-5th stimulus at slow-rate RNS — the physiological basis of the decremental response.
Mnemonic — m for “many vesicles”, q for “quantum punch”
m is the count: how many vesicles release per impulse. Reduced in presynaptic disease (LEMS, botulism) where the calcium-driven release machinery fails. q is the punch: how big the EPP a single quantum produces. Reduced in postsynaptic disease (MG) where receptor loss makes each quantum less effective. EPP = m × q. Both classes lower the product, but boards distinguish them by which factor is the culprit.
It is defined as the ratio of the end-plate potential amplitude to the threshold required for a muscle fiber action potential. Under normal, healthy conditions, the end-plate potential is engineered to be approximately 2 to 4 times larger than the threshold needed to fire the muscle. That excess capacity guarantees reliable transmission even when the nerve is firing at incredibly high frequencies.
— EDX-13 podcast, ~06:09